Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
BIOA on Nasdaq
There are no Buy or Sell transactions made by Vijay Satyanand Pande since 12 Feb 2025
Holdings reported by Vijay Satyanand Pande for BioAge Labs, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,269,072 |
$22,843,296 |
$18.00 |
01 Oct 2024 |
AH Bio Fund I, L.P. |
|
|
| Common Stock |
1,119,195 |
$20,145,510 |
$18.00 |
03 Oct 2024 |
Andreessen Horowitz LSV Fund III, L.P. |
|
|
| Common Stock |
655,294 |
$11,795,292 |
$18.00 |
01 Oct 2024 |
AH Bio Fund IV, L.P. |
|
|
| Common Stock |
189,609 |
$3,412,962 |
$18.00 |
01 Oct 2024 |
AH Bio Fund III, L.P. |
|
|
| Stock Option (Right to Buy) |
22,000 |
|
|
07 Aug 2025 |
Direct |
Common Stock |
|
| Series A-1 Preferred Stock |
0 |
|
|
27 Sep 2024 |
AH Bio Fund I, L.P. |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
27 Sep 2024 |
AH Bio Fund I, L.P. |
Common Stock |
|
| Series C Preferred Stock |
0 |
|
|
27 Sep 2024 |
AH Bio Fund III, L.P. |
Common Stock |
|
| Series D Preferred Stock |
0 |
|
|
27 Sep 2024 |
AH Bio Fund IV, L.P. |
Common Stock |
|
Transactions reported by Vijay Satyanand Pande for BioAge Labs, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.